Background. Systemic Lupus Erythematosus (SLE) is a complex systemic autoimmune disease with diverse multisystem manifestations. The prevalence of lupus in Indonesia is estimated at 0.5%. Patient satisfaction with treatment reflects subjective perceptions of therapeutic effectiveness, convenience, and side effects, and is closely related to adherence and long-term treatment continuity. To date,…
Background. Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder characterized by inflammation and multi-organ involvement. Its management requires a long-term multidisciplinary approach, which poses challenges for patients to maintain medication adherence. Poor adherence often leads to inadequate disease control, as reflected by higher disease activity, and worsened prognosis. T…
Background: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease characterized by a wide spectrum of clinical manifestations, ranging from mild cutaneous abnormalities to severe organ dysfunction. Previous studies have shown a decrease in lymphocyte count, or lymphopenia, in SLE patients, which is often associated with disease activity. However, research on the relationship betwee…
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease that involves various body systems and produces various autoantibodies. One of the autoantibodies in SLE is anti-double stranded deoxyribonucleic acid (anti-dsDNA) which is found in 70% of patients with SLE. Anti-dsDNA antibody has high specificity so it has been used as an indicator of disease activity. This study aims to dete…
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that affects many organs. Hospital information system data in 2016 has reported 2,166 hospitalized patients with lupus in 858 hospitals and 550 of them died. Evaluation of disease activity is essential to determine appropriate therapy and prevent complications. This study aims to analyze the association of hematological inflamma…
Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease with an increasing prevalence over the past few decades. Current treatments for SLE focus on controlling and managing disease activity. Hydroxychloroquine (HCQ), corticosteroids (CS), and immunosuppressants form the cornerstone of long-term SLE therapy. While studies continue to explore the effectiveness of various combinations …
Backgroud: Systemic Lupus Eritematosus (SLE) is an autoimmune condition that affects multiple organs and often induced periods of remission and relapse. One of the therapies used is cyclophosphamide. However, previous studies have shown that cyclophosphamide has side effects, including lymphopenia. Methods: This studies is an analitic observational study with a cross sectional study design. Dat…
Background: Systemic Lupus Erythematosus (SLE) is a chronic, multisystem autoimmune disease with a relapsing-remitting course that requires long-term management and ongoing monitoring. Pediatric patients with SLE face challenges in maintaining medication adherence, monitoring symptoms, and maintaining personal medical records. The use of mobile health technology, such as the "Lupie Diary" app, …
Background. Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease which is also known as the "thousand faces" disease because it has a wide range of clinical manifestations as well as a varied course of disease and prognosis. The etiological mechanism of SLE is not fully understood, so there is often a mistake in recognizing lupus, causing delays in the diagnosis and m…
Systemic lupus erythematosus in children has higher disease activity and disease burden than SLE in adults. Clinical manifestations in SLE patients are highly variable, can have different combinations of symptoms and also tend to mimic other medical conditions. The features of early manifestations at disease onset of SLE are very important in early diagnosis and referral. In addition, several i…
Background: Systemic Lupus Erythematosus (SLE) is an autoimmune disease that marked by the damage of cells and organs because of the bonding between tissues and autoantibody and immune complexes. The aim of SLE treatment is to increase survival rate and quality of patients. SLE has many clinical manifestations so it is hard to diagnose SLE patient. Mcthod: This was a descriptive observational s…
Introduction: Systemic Lupus Erythematosus (SLE) is a severe, multisystem autoimmune disease in which a person's immune system attacks their own body. The prevalence of SLE in 2018 was 7.3 cases per 100,000 population, the majority of whom were women of productive age. Neuropsychiatry is a common clinical manifestation in SLE patients in the form of mood disturbances (depression) and anxiety wh…
Introduction: Systemic Lupus Erythematosus (SLE) is an autoimmune disease with complex pathogenesis with broad clinical manifestations, more common in women of reproductive age between 15-44 years, so there is an increased incidence of pregnancies. Methods: This study was a descriptive observational study with a cross-sectional design using medical records of patients in Dr. Mohammad Hoesin Hos…